Expertise in
8
conditions

Antonio Olveira

La Paz, MD, ES 
Expertise in
8
conditions
La Paz, MD, ES 

Overview

Antonio Olveira practices practicing medicine in La Paz, Spain.

Mr. Olveira is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Cirrhosis, Hepatitis, and Non-Alcoholic Fatty Liver Disease.

He is actively involved in clinical research, co-authoring 64 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

La Paz, MD, Spain
Other Locations
La Paz, CN, Spain
Castellana, MD 28046, Spain
Madrid, MD, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase III, Randomized, Double Blind, Dummy-Controlled Study of ThermoDox® (Lyso-Thermosensitive Liposomal Doxorubicin-LTLD) in Hepatocellular Carcinoma (HCC) Using Standardized Radiofrequency Ablation (RFA) Treatment Time ≥ 45 Minutes for Solitary Lesions ≥ 3 cm to ≤ 7 cm
A Phase III, Randomized, Double Blind, Dummy-Controlled Study of ThermoDox® (Lyso-Thermosensitive Liposomal Doxorubicin-LTLD) in Hepatocellular Carcinoma (HCC) Using Standardized Radiofrequency Ablation (RFA) Treatment Time ≥ 45 Minutes for Solitary Lesions ≥ 3 cm to ≤ 7 cm
Enrollment Status: Completed
Publish Date: August 20, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, Open Label, Multicentric Clinical Trial of a Single Arm of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotype 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A
A Phase III, Open Label, Multicentric Clinical Trial of a Single Arm of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotype 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A
Enrollment Status: Withdrawn
Publish Date: June 08, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

64 Total Publications

Multidisciplinary Management in Psoriasis: A Structured Approach for Early Comorbidity Detection and Referral.
Multidisciplinary Management in Psoriasis: A Structured Approach for Early Comorbidity Detection and Referral.
Journal: Dermatology and therapy
Published: February 06, 2026

Frequently Asked Questions about Antonio Olveira

Is Antonio Olveira a top-rated expert for Hepatitis C?

MediFind is an objective health platform that identifies experts based on real-world data. Antonio Olveira is classified as an Distinguished expert for Hepatitis C, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Antonio Olveira participate in research or clinical trials?

Yes. Antonio Olveira has published 64 articles and abstracts on conditions like Hepatitis C. You can view a list of Antonio Olveira's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Olveira's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile